Gastroenterology

Researchers performed genetic analyses on more than 253,800 patients to classify variants associated with idiosyncratic drug-induced liver injury.

The American Gastroenterological Association has published new recommendations on which therapies are best for the management of mild-to-moderate ulcerative colitis.

Researchers of a new study hope the results will help guide clinicians’ decision making when screening for celiac disease in children and avoid unnecessary invasive follow-up diagnostic testing.

Dr David Schnadower and colleagues in the PECARN probiotic trial assessed the effect of Lactobacillus rhamnosus GG among more than 900 children with acute gastroenteritis.

Researchers of the CALIBER study compared the effectiveness of PPIs with laparoscopic magnetic sphincter augmentation among more than 150 patients with GERD with moderate-to-severe regurgitation.

Infection with HCV has been shown to be associated with an increased risk of cardiovascular disease events, but whether treatment with DAA agents affects this risk is currently unclear.

A new study presented during a late-breaking session at The Liver Meeting evaluated the safety and efficacy of oral seladelpar among more than 100 patients with primary biliary cholangitis.

In a new study, researchers from Mayo Clinic assessed whether immune reactivity against certain epitopes can identify biomarkers in celiac disease.

Maintenance therapy with infliximab—an anti-tumor necrosis factor agent—is standard treatment for moderate to severe pediatric inflammatory bowel disease (IBD).

PHILADELPHIA—Following the lead of other specialties and pursuing a personali